Advisor Os, LLC Novo Nordisk A S Transaction History

Advisor Os, LLC

$968 Million
Q3 2024

A detailed history of Advisor Os, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Advisor Os, LLC holds 13,633 shares of NVO stock, worth $1.45 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

13,633

Previous 13,972 2.43%

Holding current value

$1.45 Million

Previous $1.99 Million 18.61%

% of portfolio

0.17%

Previous 0.23%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	SELL	$119.07 - $145.42 $40,364 - $49,297	-339 Reduced 2.43%	13,633 $1.62 Million
Q2 2024 Aug 05, 2024	BUY	$122.71 - $146.91 $10,062 - $12,046	82 Added 0.59%	13,972 $1.99 Million
Q1 2024 May 08, 2024	BUY	$102.11 - $135.92 $77,399 - $103,027	758 Added 5.77%	13,890 $1.78 Million
Q4 2023 Feb 07, 2024	SELL	$87.78 - $105.45 $17,731 - $21,300	-202 Reduced 1.51%	13,132 $1.36 Million
Q3 2023 Nov 02, 2023	BUY	$90.94 - $199.54 $741,070 - $1.63 Million	8,149 Added 157.16%	13,334 $1.21 Million
Q2 2023 Aug 08, 2023	BUY	$155.98 - $172.65 $53,813 - $59,564	345 Added 7.13%	5,185 $839,000
Q1 2023 Apr 24, 2023	SELL	$132.34 - $159.14 $179,320 - $215,634	-1,355 Reduced 21.87%	4,840 $770,000
Q4 2022 Jan 31, 2023	BUY	$102.55 - $135.33 $82,860 - $109,346	808 Added 15.0%	6,195 $838,000
Q3 2022 Nov 03, 2022	BUY	$95.28 - $116.93 $34,872 - $42,796	366 Added 7.29%	5,387 $537,000
Q2 2022 Aug 02, 2022	BUY	$103.24 - $121.81 $72,061 - $85,023	698 Added 16.15%	5,021 $561,000
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $402,471 - $486,510	4,323 New	4,323 $480,000

Others Institutions Holding NVO

# of Institutions

1,955

Shares Held

320M

Call Options Held

5.49M

Put Options Held

7.78M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $240B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Os, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Advisor Os, LLC with notifications on news.

Account